Arkolith/Insider Trading/PAND/Form 4

Stagliano Nancy

DirectorPandion Therapeutics, Inc. (PAND) · full profile →Form 4 · filed Apr 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2021Tender(U)1K$60.00$60K0
Apr 1, 2021Tender(U)73K$60.00$4.4M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2021Disposed to issuer(D)18K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-014447) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML